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Rubicon is a protein known to engage the Beclin-1/Vps34-PI3K/UVRAG complex and inhibit endosome and
autophagosomal fusion with lysosomes. Yang et al. (2012) uncover new roles for this adaptor protein within
noncanonical p22phox or CARD9 complexes that regulate oxidative and cytokine responses in activated
macrophages, respectively. Both complexes impact pathogen-specific host defense.Few metazoan cells exhibit the biosyn-
thetic and biodestructive potential of
an activated macrophage (MacMicking,
2009). These tissue-adapted phago-
cytes not only sample and digest their
internalized prey, but also integrate an
assortment of environmental signals
and secrete upwards of a 100 chemically
distinct bioactive products, ranging from
cytokines, chemokines, and other solu-
ble messengers to diatomic gasses,
antimicrobial peptides, and cell matrix
proteins (Nathan, 1987). Such a startling
array of products helps mobilize immune
responses at the beginning of infection,
aids resolution once infection is cleared,
and may limit tissue damage through-
out. In this way, macrophages serve
as key players both in classical host
resistance to infection as well as the
emerging concept of disease tolerance
(MacMicking, 2009; Medzhitov et al.,
2012).
A major question is, how are such
diverse processes deployed and hierar-
chically coordinated within macro-
phages? Part of the answer now lies
with a versatile adaptor protein called
Rubicon, which, like its historical Romannamesake, defines a boundary that
when crossed often leads to a point of
no return—in this case, armed conflict
with bacterial, fungal and viral pathogens.
Two papers in this issue of Cell Host
and Microbe provide examples of how
Rubicon manages to integrate different
environmental signals for orchestrat-
ing pathogen-selective macrophage re-
sponses (Yang et al., 2012a, 2012b)
(Figure 1). Such selectivity relies on Rubi-
con’s ability to assemble or disassemble
different immune complexes following
detection of bacterial, fungal, or viral
ligands (called ‘‘pathogen-associated
molecular patterns,’’ or PAMPs) by a set
of germline-encoded pattern recognition
receptors (PRRs). These PRRs are distrib-
uted either on the macrophage surface,
within the cytosol, or inside membrane-
bound compartments where they engage
different PAMPs. Here, the authors
found Rubicon operates downstream of
three specific PRRs: Toll-like receptor-2
(TLR2), which detects bacterial lipopro-
teins and yeast cell wall zymosans
primarily at the cell surface; Dectin-1,
which engages fungal b-glucans in the
same location; and the retinoic acidinducible gene, Rig-I, which senses
double-stranded viral RNA in the cytosol.
Under basal conditions, Rubicon nor-
mally acts as a negative regulator of the
Beclin-1/Vps34-class III phosphatidylino-
sitol-3-kinase (PI3K)/UVRAG complex
required for fusion of endosomes and
autophagosomes with lysosomes (Mat-
sunaga et al., 2009; Zhong et al., 2009)
(Figure 1). Rubicon confers these effects
by interfering with Vps34 lipid kinase
activity and sequestering UVRAG from
class C VPS, the latter of which acts as
a Rab7 guanine nucleotide exchange
factor to load GTP onto the Rab7 GTPase
for stimulating late endosomal fusion
(Zhong et al., 2009; Sun et al., 2010).
In activated macrophages, however,
Rubicon is called upon to perform addi-
tional tasks, helping assemble two new
autophagy-independent complexes that
appear critical for host defense. The first
of these complexes involves Rubicon
binding to p22phox following TLR2 stimu-
lation to promote oxidant killing of
bacteria (Yang et al., 2012a) (Figure 1).
p22phox is a component of several
NADPH oxidases (NOXs) responsible for
generating the superoxide anion (O2
)1, March 15, 2012 ª2012 Elsevier Inc. 221
Figure 1. Rubicon Is a Multidomain Adaptor Protein that Assembles
Different Protein Complexes under Basal and PRR-Activated
Conditions in Macrophages
These complexes govern diverse host immune output pathways that impact
the ability to control different pathogen classes, namely bacteria, viruses,
and fungi. Such outputs include positive regulation of NADPH oxidase
(NOX2) assembly for superoxide (O2
) generation (denoted by blue arrows)
and control of bacterial pathogens, as well as negative regulation of the
CARD9/Bcl10-MALT-1 complex and downstream inflammatory cytokine
production (denoted by blocked red lines). The latter outcome renders the
host more susceptible to viral and fungal pathogens.
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reactive oxygen species
(ROS). Macrophages express
NOX2 phagocyte oxidase,
which governs the respiratory
burst in neutrophils, mono-
cytes, macrophages, and
eosinophils (Nathan, 1987).
This oxidoreductase com-
prises two membrane-span-
ning subunits—p22phox and
gp91phox—used in direct
electron transfer to terminal
acceptors for producing O2

as well as three cytosolic
subunits—p67phox, p47phox
and p40phox—that regulate
NOX2 activation and mem-
brane assembly.
Rubicon was found to
specifically stabilize the
p22phox-gp91phox complex,
and this binding was essen-
tial for ROS production via
early recruitment of p22phox
to phagosomes containing
TLR2 ligands or the gram-positive bacterium, Listeria mononcyto-
genes. Such recruitment coincided with
control of infection. Synergistic effects
on ROS production were also evident
when TLR2 ligands or Listeriawere added
together with the macrophage-activating
cytokine, IFN-g, a combination likely to
co-opt IFN-inducible guanylate binding
proteins (GBPs) that also recruits
p22phox to Listeria phagosomes (Kim
et al., 2011; MacMicking, 2009). Remark-
ably, these activating effects were both
functionally and genetically separable
from the inhibitory action of Rubicon on
Beclin-1/Vps34-PI3K/UVRAG; here, the
use of deletion mutants revealed different
domains of Rubiconwere involved in each
activity.
A contrasting picture emerged in acti-
vated macrophages after encounter with
fungal and viral ligands. Engagement of
Dectin-1 by fungal b-glucans and stimula-
tion of the intracellular pattern recognition
receptor Rig-I by RNA viruses (VSV,
Sendai, and influenza A) led Rubicon to
associate with the caspase recruitment
domain-containing protein, CARD9 (Yang
et al., 2012b) (Figure 1). In myeloid cells,
CARD9 normally couples Dectin-1-Syk
kinase signaling to the NF-kB pathway
via formation of a trimolecular complex
containing CARD9, the adaptor B cell222 Cell Host & Microbe 11, March 15, 2012lymphoma 10 protein (Bcl10) and the
paracaspase, MALT1 (CARD9-Bcl10-
MALT1; CBM) (Gross et al., 2006). This
signaling activates NF-kB-dependent
cytokine production needed for antifungal
immunity.
Yang et al. found Rubicon instead
dampened the inflammatory cytokine
(TNF-a, IL-1b, and IL-6) response to these
ligands by displacing CARD9 from the
CBM complex (Yang et al., 2012b). This
displacement appeared dependent on
the serine phosphorylation status of
Rubicon, which is otherwise bound to
a phospho-serine/threonine binding pro-
tein, 14-3-3b; Rubicon thus likely under-
goes dephosphorylation and possibly
conformational change for it to be re-
leased from 14-3-3b to engage CARD9.
Indeed, mutation of serine 248 within an
N-terminal serine-rich domain that is nor-
mally phosphorylated led Rubicon to
associate constitutively with CARD9 and
prevent it from participating in the CMB
complex.
Overall these data suggest Rubicon
negatively regulates inflammatory cyto-
kine production in response to Dectin-
1-dependent fungal ligands and Rig-I-
dependent sensing of RNA viruses; both
effects operate through CARD9 seques-
tration by Rubicon following its dephos-ª2012 Elsevier Inc.phorylation at serine 248 to
exchange partners for 14-3-
3b. Again, such interactions
appeared physically distinct
from Beclin-1/Vps34-PI3K/
UVRAG or p22phox-gp91phox
complexes, revealing a re-
markable level of molecular
discrimination to coordinate
these three different outputs.
In both papers, compelling
in vivo evidence reinforced
the authors’ biochemical con-
clusions (Yang et al., 2012a,
2012b). Mice silenced for
Rubicon via shRNA-express-
ing adenovirus were uni-
formly susceptible to Listeria,
which requires NOX2 for con-
trol (Kim et al., 2011), whereas
mice conditionally overex-
pressing Rubicon within
macrophages or globally had
augmented resistance. In
contrast, blocking important
antifungal and antiviral cyto-
kines by Rubicon overexpres-sion increased susceptibility to Candida
albicans and influenza A virus challenge,
while extinguishing Rubicon expression
derepressed immune activation and
led to greater resistance. This functional
dichotomy suggests that Rubicon may
also serve as a decision-making hub
to tailor pathogen-specific immunity
in vivo.
While the identification of Rubicon as
an organizer of certain PRR responses
brings much-needed molecular clarity
to understanding host defense, a number
of questions still remain with respect
to its divergent activities. First, how do
the serine-rich N- and C-terminal regions
of Rubicon regulate opposing effects
on inflammatory cytokine production
in response to different stimuli? Are
these regions influenced by posttransla-
tional modifications other than serine
phosphorylation? Moreover, how does
Rubicon’s dual role in promoting ROS
production square with its ability to
block autophagolysosomal fusion, both
of which seem to be needed for control-
ling Listeria in activated macrophages
(Kim et al., 2011)? Future experiments
should help resolve some of these
issues. And finally, given Rubicon’s
multifunctional profile, are there other
immune complexes that it possibly
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tion? One interesting candidate is the
inflammasome response following en-
gagement of Dectin-1 that was recently
found to enlist a noncanonical cas-
pase-8 pathway to generate interleukin-
1b following cleavage of its immature
pro-form (Gringhuis et al., 2012).
Because Rubicon inhibits IL-1b in
response to fungal b-glucans (Yang
et al., 2012b), it may also displace com-
ponents of the inflammasome machinery
like it does with the CBM complex to
regulate this important host pathway
(Figure 1).
Crossing the Rubicon will therefore
likely uncover myriad new functions for
this adaptor protein and reinforce the
notion that many roads lead to host
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RIP3-regulated necrosis has recently emerged as an important antiviral host defense mechanism. A new
study by Upton et al. (2012) identifies DAI, a cytoplasmic DNA sensor, as a partner of RIP3 that is essential
for the induction of regulated necrosis in cytomegalovirus-infected cells.Viruses depend on the intracellular
machinery of the host to produce various
viral components that are required for
replication and virion production. There-
fore, infected cells need to stay alive for
a sufficient period of time to allow viral
replication. Elimination of infected cells
by regulated cell death (RCD) is a fun-
damental mechanism of antiviral host
defense. Locked in an eternal arms race,
hosts are forced to develop ways to kill
infected cells, and viruses struggle to
prevent the premature demise of their
host cells by expressing inhibitors of cell
death. Understanding the mechanisms
inducing the death of infected cells and
the viral strategies to circumvent themwill be essential for the development of
better antiviral therapies. Until recently,
RCD was considered synonymous with
apoptosis; however, necrosis that ismedi-
ated by the receptor interacting protein
(RIP) family of kinases is now recognized
as another type of RCD. Best studied in
TNF receptor 1 (TNFR1)-induced death
signaling, regulated necrosis (also termed
necroptosis) requires RIP1 and RIP3
activity and usually occurs under condi-
tions in which the activity of the proapo-
ptotic protein caspase 8 is compromised
(Mocarski et al., 2011).
Murine cytomegalovirus (MCMV)
possesses several proteins capable of
suppressing cell death (Mocarski et al.,2011). In a previous study, Mocarski and
colleagues showed that one of these
proteins, the viral inhibitor of RIP activa-
tion (vIRA), which contains a RIP homo-
typic interaction motif (RHIM), prevents
the death of MCMV-infected cells by
disrupting the RHIM-dependent forma-
tion of a RIP3-containing protein complex
that induces regulated necrosis (Upton
et al., 2010). MCMV expressing a RHIM
mutant vIRA (M45mutRHIM) was unable
to establish productive infection in wild-
type mice, but replicated efficiently in
RIP3-deficient mice, demonstrating that
RIP3-dependent necrosis of infected cells
is important for antiviral host defense.
While MCMV-induced necrosis requires1, March 15, 2012 ª2012 Elsevier Inc. 223
